Takeover offer made for Prospa
That's a fraction of the A$610 million valuation when Prospa listed on the ASX in 2019.
The offer is subject to a number of conditions, including the approval of Australia's Foreign Investment Review Board and of Prospa shareholders.
The offer is either 45 Australian cents per share or shares in a new unlisted public company named PGL Holdco, but holders of at least 74% of Prospa must elect the scrip option for the takeover to succeed.
The cash consideration will be partly funded by Prospa lending the consortium up to A$12 million and that will also require Prospa shareholders' approval – a meeting to approve this funding is planned to be held immediately before a meeting to vote on the scheme.
Click the button below to subscribe and will have free unlimited access for a limited time to full article and all other articles on the site.
You will also be able to comment on articles on Good Returns.